Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies-Reference-Cited by-同舟云学术

Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies

Published:2022-01 Issue:9 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Viveiros Nicole¹^ORCID,Flores Bianca CT¹^ORCID,Lobo João¹²³^ORCID,Martins‐Lima Cláudia¹⁴,Cantante Mariana¹²,Lopes Paula¹²,Deantonio Cecilia⁵,Palu Cintia⁵^ORCID,Sainson Richard CA⁵^ORCID,Henrique Rui¹²³^ORCID,Jerónimo Carmen¹³^ORCID

Affiliation:

1. Cancer Biology and Epigenetics Group Research Center of IPO Porto (CI‐IPOP)/RISE@CI‐IPOP (Health Research Network) Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC) Porto Portugal

2. Department of Pathology Portuguese Oncology Institute of Porto (IPO Porto) Porto Portugal

3. Department of Pathology and Molecular Immunology School of Medicine and Biomedical Sciences– University of Porto (ICBAS‐UP) Porto Portugal

4. Department of Precision Medicine University of Campania “Luigi Vanvitelli” Naples Italy

5. Kymab, a Sanofi Company Cambridge UK

Funder

Fundação para a Ciência e a Tecnologia

Instituto Português de Oncologia do Porto

Università degli Studi della Campania Luigi Vanvitelli

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1402

Reference76 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. The health economics of bladder cancer

3. Financial Toxicity of Having Bladder Cancer

4. The global burden of urinary bladder cancer: an update

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Review on Cancer Pathology from Aberrant Histone Chaperone Activity;International Journal of Molecular Sciences;2024-06-10

2. Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial Carcinoma after BCG Immunotherapy;International Journal of Molecular Sciences;2024-04-27

3. Exploring the transcriptomic landscape of BLCA: SHTN1 as a key player in photodynamic therapy response;2024-03-29

4. CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer;Cancers;2023-11-22

5. Comprehensive Landscape of Non-muscle Invasive Bladder Cancer Tumour Microenvironment and Prognostic value of Cancer-Associated Myofibroblasts;2023-10-27